PVWM
AGN

Point View Wealth Management’s Allergan plc AGN Stock Holding History

Point View Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4,341
Closed -$769K – 267
2020
Q1 		$769K Buy
4,341
+46
+1% +$8.66K 0.42% 84
2019
Q4 		$821K Sell
4,295
-154
-3% -$27.8K 0.34% 101
2019
Q3 		$749K Sell
4,449
-568
-11% -$92.5K 0.34% 95
2019
Q2 		$840K Sell
5,017
-557
-10% -$77.1K 0.36% 92
2019
Q1 		$816K Sell
5,574
-124
-2% -$18K 0.36% 97
2018
Q4 		$762K Buy
5,698
+683
+14% +$112K 0.38% 91
2018
Q3 		$955K Buy
5,015
+516
+11% +$94.8K 0.42% 76
2018
Q2 		$750K Buy
4,499
+161
+4% +$25.8K 0.35% 103
2018
Q1 		$730K Sell
4,338
-58
-1% -$9.73K 0.35% 104
2017
Q4 		$719K Sell
4,396
-407
-8% -$73K 0.34% 105
2017
Q3 		$985K Buy
4,803
+92
+2% +$21.4K 0.47% 69
2017
Q2 		$1.15M Buy
4,711
+56
+1% +$13.2K 0.56% 58
2017
Q1 		$1.11M Buy
4,655
+215
+5% +$50.1K 0.57% 57
2016
Q4 		$932K Buy
4,440
+1,325
+43% +$274K 0.54% 61
2016
Q3 		$717K Buy
3,115
+282
+10% +$68.9K 0.43% 87
2016
Q2 		$655K Buy
2,833
+1,201
+74% +$277K 0.4% 91
2016
Q1 		$437K Buy
1,632
+906
+125% +$259K 0.28% 119
2015
Q4 		$227K Buy
+726
New +$216K 0.16% 174

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Point View Wealth Management's AGN Position: Q2 2020 in Review

Point View Wealth Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 4,341 shares — an estimated $769K sold.

Point View Wealth Management first reported a position in AGN in Q4 2015 and held it in 18 quarters. The position peaked at $1.15M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Point View Wealth Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Point View Wealth Management sold 4,341 Allergan plc shares in Q2 2020, an estimated $769K.
  • Point View Wealth Management first reported a position in Allergan plc in Q4 2015 and held it in 18 quarters.
  • Point View Wealth Management's Allergan plc position peaked at $1.15M in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Point View Wealth Management's 13F filing for Q2 2020, filed 29 Jul 2020.